Making Vaccines Accessible
Despite the challenges and high cost of development, vaccine innovation is at an all-time high, as new approaches aim to improve global access.
Vaccines have had a tremendous impact on human quality of life, increasing life expectancies by eradicating deadly diseases. The cost of developing and manufacturing vaccines remains extremely high, however. Given unprofitable prices, improving access to vaccines has been a major challenge. Despite these problems, innovation is reaching a new level, while new approaches to manufacturing and distribution involving non-government organizations and contract manufacturers offshore have helped improve access. This article touches on some of the innovations, and the types of business models that have made them possible, and includes an interview with the director of the Sabin Institute.
Download the
Vaccine Development and Manufacturing 2017 ebook.
Article Details
Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
November 2017
Pages: 4–10
Citation
When referring to this article, please cite it as A. Shanley, "Making Vaccines Accessible," Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
